Report Detail
Global Rapid Adenovirus Testing Market Growth (Status and Outlook) 2022-2028
- RnM4374351 |
- 18 January, 2022 |
- Global |
- 87 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Rapid Adenovirus Testing will have significant change from previous year. According to our (LP Information) latest study, the global Rapid Adenovirus Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rapid Adenovirus Testing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Rapid Adenovirus Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rapid Adenovirus Testing market, reaching US$ million by the year 2028. As for the Europe Rapid Adenovirus Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rapid Adenovirus Testing players cover Biopanda Reagents, CTK Biotech, Creative Diagnostics, and Biomerieux, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Adenovirus Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Blood Antigen Tests
Stool Antigen Tests
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Diagnostic Laboratories
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Biopanda Reagents
CTK Biotech
Creative Diagnostics
Biomerieux
Accuquik
SA Scientific
Diasorin S.P.A
QIAGEN
Quidel Corporation
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Rapid Adenovirus Testing Market Size 2017-2028
- 2.1.2 Rapid Adenovirus Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Rapid Adenovirus Testing Segment by Type
- 2.2.1 Blood Antigen Tests
- 2.2.2 Stool Antigen Tests
- 2.3 Rapid Adenovirus Testing Market Size by Type
- 2.3.1 Rapid Adenovirus Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Rapid Adenovirus Testing Market Size Market Share by Type (2017-2022)
- 2.4 Rapid Adenovirus Testing Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Diagnostic Laboratories
- 2.4.3 Clinics
- 2.5 Rapid Adenovirus Testing Market Size by Application
- 2.5.1 Rapid Adenovirus Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Rapid Adenovirus Testing Market Size Market Share by Application (2017-2022)
3 Rapid Adenovirus Testing Market Size by Player
- 3.1 Rapid Adenovirus Testing Market Size Market Share by Players
- 3.1.1 Global Rapid Adenovirus Testing Revenue by Players (2020-2022)
- 3.1.2 Global Rapid Adenovirus Testing Revenue Market Share by Players (2020-2022)
- 3.2 Global Rapid Adenovirus Testing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Rapid Adenovirus Testing by Regions
- 4.1 Rapid Adenovirus Testing Market Size by Regions (2017-2022)
- 4.2 Americas Rapid Adenovirus Testing Market Size Growth (2017-2022)
- 4.3 APAC Rapid Adenovirus Testing Market Size Growth (2017-2022)
- 4.4 Europe Rapid Adenovirus Testing Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Rapid Adenovirus Testing Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Rapid Adenovirus Testing Market Size by Country (2017-2022)
- 5.2 Americas Rapid Adenovirus Testing Market Size by Type (2017-2022)
- 5.3 Americas Rapid Adenovirus Testing Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Rapid Adenovirus Testing Market Size by Region (2017-2022)
- 6.2 APAC Rapid Adenovirus Testing Market Size by Type (2017-2022)
- 6.3 APAC Rapid Adenovirus Testing Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Rapid Adenovirus Testing by Country (2017-2022)
- 7.2 Europe Rapid Adenovirus Testing Market Size by Type (2017-2022)
- 7.3 Europe Rapid Adenovirus Testing Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Rapid Adenovirus Testing by Region (2017-2022)
- 8.2 Middle East & Africa Rapid Adenovirus Testing Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Rapid Adenovirus Testing Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Rapid Adenovirus Testing Market Forecast
- 10.1 Global Rapid Adenovirus Testing Forecast by Regions (2023-2028)
- 10.1.1 Global Rapid Adenovirus Testing Forecast by Regions (2023-2028)
- 10.1.2 Americas Rapid Adenovirus Testing Forecast
- 10.1.3 APAC Rapid Adenovirus Testing Forecast
- 10.1.4 Europe Rapid Adenovirus Testing Forecast
- 10.1.5 Middle East & Africa Rapid Adenovirus Testing Forecast
- 10.2 Americas Rapid Adenovirus Testing Forecast by Country (2023-2028)
- 10.2.1 United States Rapid Adenovirus Testing Market Forecast
- 10.2.2 Canada Rapid Adenovirus Testing Market Forecast
- 10.2.3 Mexico Rapid Adenovirus Testing Market Forecast
- 10.2.4 Brazil Rapid Adenovirus Testing Market Forecast
- 10.3 APAC Rapid Adenovirus Testing Forecast by Region (2023-2028)
- 10.3.1 China Rapid Adenovirus Testing Market Forecast
- 10.3.2 Japan Rapid Adenovirus Testing Market Forecast
- 10.3.3 Korea Rapid Adenovirus Testing Market Forecast
- 10.3.4 Southeast Asia Rapid Adenovirus Testing Market Forecast
- 10.3.5 India Rapid Adenovirus Testing Market Forecast
- 10.3.6 Australia Rapid Adenovirus Testing Market Forecast
- 10.4 Europe Rapid Adenovirus Testing Forecast by Country (2023-2028)
- 10.4.1 Germany Rapid Adenovirus Testing Market Forecast
- 10.4.2 France Rapid Adenovirus Testing Market Forecast
- 10.4.3 UK Rapid Adenovirus Testing Market Forecast
- 10.4.4 Italy Rapid Adenovirus Testing Market Forecast
- 10.4.5 Russia Rapid Adenovirus Testing Market Forecast
- 10.5 Middle East & Africa Rapid Adenovirus Testing Forecast by Region (2023-2028)
- 10.5.1 Egypt Rapid Adenovirus Testing Market Forecast
- 10.5.2 South Africa Rapid Adenovirus Testing Market Forecast
- 10.5.3 Israel Rapid Adenovirus Testing Market Forecast
- 10.5.4 Turkey Rapid Adenovirus Testing Market Forecast
- 10.5.5 GCC Countries Rapid Adenovirus Testing Market Forecast
- 10.6 Global Rapid Adenovirus Testing Forecast by Type (2023-2028)
- 10.7 Global Rapid Adenovirus Testing Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Biopanda Reagents
- 11.1.1 Biopanda Reagents Company Information
- 11.1.2 Biopanda Reagents Rapid Adenovirus Testing Product Offered
- 11.1.3 Biopanda Reagents Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Biopanda Reagents Main Business Overview
- 11.1.5 Biopanda Reagents Latest Developments
- 11.2 CTK Biotech
- 11.2.1 CTK Biotech Company Information
- 11.2.2 CTK Biotech Rapid Adenovirus Testing Product Offered
- 11.2.3 CTK Biotech Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 CTK Biotech Main Business Overview
- 11.2.5 CTK Biotech Latest Developments
- 11.3 Creative Diagnostics
- 11.3.1 Creative Diagnostics Company Information
- 11.3.2 Creative Diagnostics Rapid Adenovirus Testing Product Offered
- 11.3.3 Creative Diagnostics Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Creative Diagnostics Main Business Overview
- 11.3.5 Creative Diagnostics Latest Developments
- 11.4 Biomerieux
- 11.4.1 Biomerieux Company Information
- 11.4.2 Biomerieux Rapid Adenovirus Testing Product Offered
- 11.4.3 Biomerieux Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Biomerieux Main Business Overview
- 11.4.5 Biomerieux Latest Developments
- 11.5 Accuquik
- 11.5.1 Accuquik Company Information
- 11.5.2 Accuquik Rapid Adenovirus Testing Product Offered
- 11.5.3 Accuquik Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Accuquik Main Business Overview
- 11.5.5 Accuquik Latest Developments
- 11.6 SA Scientific
- 11.6.1 SA Scientific Company Information
- 11.6.2 SA Scientific Rapid Adenovirus Testing Product Offered
- 11.6.3 SA Scientific Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 SA Scientific Main Business Overview
- 11.6.5 SA Scientific Latest Developments
- 11.7 Diasorin S.P.A
- 11.7.1 Diasorin S.P.A Company Information
- 11.7.2 Diasorin S.P.A Rapid Adenovirus Testing Product Offered
- 11.7.3 Diasorin S.P.A Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Diasorin S.P.A Main Business Overview
- 11.7.5 Diasorin S.P.A Latest Developments
- 11.8 QIAGEN
- 11.8.1 QIAGEN Company Information
- 11.8.2 QIAGEN Rapid Adenovirus Testing Product Offered
- 11.8.3 QIAGEN Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 QIAGEN Main Business Overview
- 11.8.5 QIAGEN Latest Developments
- 11.9 Quidel Corporation
- 11.9.1 Quidel Corporation Company Information
- 11.9.2 Quidel Corporation Rapid Adenovirus Testing Product Offered
- 11.9.3 Quidel Corporation Rapid Adenovirus Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Quidel Corporation Main Business Overview
- 11.9.5 Quidel Corporation Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Rapid Adenovirus Testing. Industry analysis & Market Report on Rapid Adenovirus Testing is a syndicated market report, published as Global Rapid Adenovirus Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Rapid Adenovirus Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
